Epttco Ltd.
This article was originally published in Start Up
Executive Summary
The never-ending search for cancer therapies has led researchers in recent years to consider enzyme-prodrug therapy, a way by which a safe, inactive prodrug is converted into a potent cytotoxic drug at a tumor site by delivery of an activating enzyme. Epttco Ltd. intends to join together several such research efforts.